argenx works in collaboration with Zai Lab with the purpose to accelerate new potential indications of clinical developments at a year by year basis. The duo commit to improving the lives of patients that suffer from cancer and severe autoimmune diseases. The license agreement of this takes place in Greater China, including mainland China, Taiwan, Hong Kong, and Macau.
argenx is building a progressive immunology company and the Zai Lab joins to expand their global footprint. In a statement by CEO of argenx, Tim Van Hauwermeiren, he states that "we aim to provide broad access to efgartigimod in these important markets as well as accelerate the number of autoimmune indications in clinical development [...] we believe that Zai Lab is the ideal partner for us ahead of our first potential approval of efgartigimod in generalized myasthenia gravis (gMG) in the U.S. and we are aligned in our mutual passion to bring potential innovative immunology therapies to patients in need.”
Image Credit: argenx
What Makes This Trend Stand Out
- Health Research Collaborations in Immunology
- Collaborations between companies specializing in immunology research is a growing trend, and creates opportunities for accelerated development of potential treatments for autoimmune diseases and cancers.
- Global Expansion of Immunology Companies
- More and more immunology companies are looking to expand their reach globally, creating increasing opportunities for partnerships and collaborations that can drive innovation.
- Focus on Patient Needs in Immunology Research
- Companies are increasingly focusing on the needs of patients in their immunology research, highlighting the need for new and innovative therapies to treat serious diseases like cancer and autoimmune disorders.
Sectors Adopting This
- Immunology Research and Development
- The industry of immunology research and development is one that is ripe for innovation and advancements in treatments for autoimmune diseases and cancer.
- Global Pharmaceuticals
- Pharmaceutical products and companies have a role to play in driving global collaborations, to accelerate drug development and delivery to those in need.
- Healthcare and Patient Services
- Healthcare providers and patient services companies can benefit from innovations in immunology research, as new advancements in medicine and treatment can provide better care options for those in need.
